Varian Halcyon Treatment System Receives ANVISA Registration in Brazil

PALO ALTO, Calif., Dec. 6, 2017 /PRNewswire/ — Further expanding the global availability of its new device for cancer treatment, Varian (NYSE: VAR) today announced the Halcyon™ system has received ANVISA registration in Brazil. This registration allows Varian to market this new system in…